pathCast Lecture | Dysplasia in Inflammatory Bowel Disease: Practical Aspects

September 20, 2022

Pathologic diagnosis of dysplasia in inflammatory bowel disease (IBD)plays an important role in deciding management options for the patients. Examination of colon biopsy can offer vital information. Histologic examination of the colonic biopsy and diagnosis of dysplasia offer vital clues for future prognosis and patient management.

Diagnosis of dysplasia in IBD is a challenge for the pathologists. It is important to learn how to correctly diagnose and categorize dysplasia in IBD . Histology plays an important role in diagnosis of dysplasia and future patient management.
 

Target Audience

Pathologists, pathology fellows, and researchers.

Learning Objectives

  • Identify dysplasia in inflammatory bowel disease (IBD).
  • Integrate and participate in multidisciplinary approach to management of IBD.
  • Utilize knowledge for future research on IBD-related dysplasia.
  • Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this pathCast Lecture | Dysplasia in Inflammatory Bowel Disease: Practical Aspects for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Activity opens: 
09/20/2022
Activity expires: 
09/21/2022
Event starts: 
09/20/2022 - 9:00am PDT
Event ends: 
09/20/2022 - 10:00am PDT
Add to calendar: 
City of Hope | Virtual

Virtual Meeting- Zoom

Deepti Dhall, MD   Professor and Director of Gastrointestinal Pathology, The University of Alabama at Birmingham School of Medicine

Dr. Deepti Dhall has indicated there are no relevant financial relationships. 

ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: City of Hope designates this live webinar for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The following credit type(s) are being offered for this course:

•  AMA PRA Category 1 Credit™  1.0

The following may apply AMA PRA Category 1 Credit™ for license renewal:

Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.

Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this pathCast Lecture | Dysplasia in Inflammatory Bowel Disease: Practical Aspects for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Please login or register to take this activity.